Sign the Resolution for a Federal Commission on Drug Policy

Contents | Feedback | Search | DRCNet Home Page | Join DRCNet

DRCNet Library | Schaffer Library | Hemp (Marijuana) | Medical Information

CANNABIS THERAPEUTIC RESEARCH

PROGRAM

REPORT to the CALIFORNIA LEGISLATURE

Prepared by the

RESEARCH ADVISORY PANEL

350 McAllister Street, Room 6000

San Francisco, California 94102

TABLE OF CONTENTS

• Panel Members and Staff
• Executive Summary
• Cancer Chemotherapy, Nausea and Vomiting
  • The-Problem
  • Inadequacy of Drugs in Current Use
  • Early Experience with Marijuana and THC
• Cannabis Therapeutic Program
  • Legislative History
  • The Research Advisory Panel
  • Panel's Role in Development of Legislation
  • Summary of Legislation
  • Extension of Law and Provision for Glaucoma Studies
• Implementation of the New Law
  • Protocol Development
  • Drug Supply
  • Cost
  • Investigator Eligibility
  • Physician Enrollment
  • Research Subjects
  • Research Subject Protection
• Study Objectives
  • Protocol History
  • Data Collection
  • Data Quality Control
  • Abuse
  • Site Visits
  • Dissemination of Findings and Results
• Detailed Protocol Results
  • Number of Patients Treated
  • Initial Trial
  • Cumulative Dose Study
  • Combination Protocol
  • Results of Study with Smoked Marijuana
  • Protocol Exceptions (Pilot Protocols)
  • Results of the Controlled Study Protocols
  • Glaucoma Protocol
  • Post Marketing Survey of Investigators
  • Discussion of Results of Cannabis Therapeutic Program
• Approval by FDA for Marketing of THC and Conclusion of the Cannabis Therapeutic Program
  • Approval and Rescheduling
  • Investigational THC no Longer Supplied by NCI
• Credits

Contents | Feedback | Search | DRCNet Home Page | Join DRCNet

DRCNet Library | Schaffer Library | Hemp (Marijuana) | Medical Information